KR970705386A - 치아 및 구강 뼈의 유지방법(methods of maintaining teeth and oralbone) - Google Patents

치아 및 구강 뼈의 유지방법(methods of maintaining teeth and oralbone)

Info

Publication number
KR970705386A
KR970705386A KR1019970701096A KR19970701096A KR970705386A KR 970705386 A KR970705386 A KR 970705386A KR 1019970701096 A KR1019970701096 A KR 1019970701096A KR 19970701096 A KR19970701096 A KR 19970701096A KR 970705386 A KR970705386 A KR 970705386A
Authority
KR
South Korea
Prior art keywords
compound
oralbone
methods
maintaining teeth
rti
Prior art date
Application number
KR1019970701096A
Other languages
English (en)
Korean (ko)
Inventor
윌리엄 로크릿지 세일즈
Original Assignee
스트링거 피터 지
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스트링거 피터 지, 일라이 릴리 앤드 캄파니 filed Critical 스트링거 피터 지
Publication of KR970705386A publication Critical patent/KR970705386A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
KR1019970701096A 1994-08-22 1995-08-21 치아 및 구강 뼈의 유지방법(methods of maintaining teeth and oralbone) KR970705386A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29423794A 1994-08-22 1994-08-22
US08/294,237 1994-08-22
PCT/US1995/010582 WO1996005829A1 (en) 1994-08-22 1995-08-21 Methods of maintaining teeth and oral bone

Publications (1)

Publication Number Publication Date
KR970705386A true KR970705386A (ko) 1997-10-09

Family

ID=23132491

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970701096A KR970705386A (ko) 1994-08-22 1995-08-21 치아 및 구강 뼈의 유지방법(methods of maintaining teeth and oralbone)

Country Status (14)

Country Link
EP (1) EP0769946A4 (cs)
JP (1) JPH10504573A (cs)
KR (1) KR970705386A (cs)
AU (1) AU692598B2 (cs)
CA (1) CA2198108A1 (cs)
CZ (1) CZ52197A3 (cs)
FI (1) FI970713A (cs)
HU (1) HUT76891A (cs)
IL (1) IL115017A0 (cs)
MX (1) MX9701331A (cs)
NO (1) NO970784D0 (cs)
WO (1) WO1996005829A1 (cs)
YU (1) YU55495A (cs)
ZA (1) ZA956987B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss

Also Published As

Publication number Publication date
MX9701331A (es) 1997-05-31
CA2198108A1 (en) 1996-02-29
ZA956987B (en) 1997-02-21
AU692598B2 (en) 1998-06-11
EP0769946A4 (en) 1997-11-05
WO1996005829A1 (en) 1996-02-29
HUT76891A (en) 1997-12-29
YU55495A (sh) 1998-07-10
NO970784L (no) 1997-02-20
AU3408895A (en) 1996-03-14
NO970784D0 (no) 1997-02-20
EP0769946A1 (en) 1997-05-02
FI970713A0 (fi) 1997-02-20
CZ52197A3 (en) 1997-08-13
FI970713A (fi) 1997-02-20
JPH10504573A (ja) 1998-05-06
IL115017A0 (en) 1995-12-08

Similar Documents

Publication Publication Date Title
KR950016725A (ko) 폐 고혈압성 질병을 억제하는 방법
KR970706818A (ko) 뉴로펩티드 y와 관련된 상태의 억제 방법(methods of inhibiting conditions associated with neuropeptide)
KR950010893A (ko) 자궁내막증 억제 방법
KR950016732A (ko) 피부 및 질의 위축 억제방법
KR950016738A (ko) 알쯔하이머 질병의 억제 방법
KR950016746A (ko) 비-펩티드 타키키닌 수용체 길항물질
KR950010892A (ko) 자궁 섬유증 억제 방법
KR950016744A (ko) 트롬빈을 저해하는 방법
KR950016723A (ko) 자가면역 질병의 억제 방법
KR950016745A (ko) 생리증상의 치료방법 및 이를 위한 조성물
KR950016731A (ko) 지루 및 좌창의 억제 방법
KR950016724A (ko) 폐경기 후 여성의 리비도를 증가시키는 방법
KR950016726A (ko) 기능부전성 자궁 출혈을 억제하는 방법
KR950010889A (ko) 혈관형성 및 혈관형성성 질병을 억제하는 방법
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
KR950016727A (ko) 트롬보모듈린 발현을 증가시키는 방법
KR950016730A (ko) 폐경기 후 증후군과 관련한 혈관 운동 증상 및 수반되는 심리학적 장애의 억제 방법
KR950010891A (ko) 내성 종양을 치료하는 방법
KR950010887A (ko) 연골 퇴화 억제 방법
KR950016742A (ko) 폐경후 여성의 씨엔에스 질환을 억제하는 방법
KR950016734A (ko) 성적 조숙증의 억제방법
KR970705384A (ko) 골 보철 파손의 억제 방법(methods for inhibiting bone prosthesis degeneration)
KR950016729A (ko) 유방 질환의 억제 방법
KR950016735A (ko) 터너 증후군의 억제 방법
KR950016741A (ko) 체중 증가를 억제하거나 또는 체중 감소를 유도하는 방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid